The most convincing argument behind pressing calls to expand the scale of activities in HIV/AIDS in developing countries is the moral and humanitarian one. Every day there are approximately 16,000 new HIV infections globally (UNAIDS 2000). Epidemiologically, the rapid transmission of HIV/AIDS can only be countered when prevention efforts are organised at sufficient scale to affect the dynamics of the epidemic. The demographics of the HIV/AIDS epidemic reveal the extent to which it is the working-age and younger generations that are disproportionately affected. Internationally, the fact that more and more adolescents are having sexual relations before marriage (Smith and Colvin 2000) and that the age at which first sexual intercourse occurs is decreasing, means the pool of young women and men at risk of contracting sexually transmitted infections generally and HIV/AIDS specifically is ever-expanding.
There is increasing frustration in development with the failure of many small-scale research, pilot or demonstration projects to get “out of the hothouse” to have a larger influence on policies and programmes (Myers 1992: 370). This frustration is perhaps more pronounced in the area of HIV/AIDS as the epidemic escalates. The World Bank report on Sub-Saharan Africa notes, for example, that among the lessons that have been learned about successful HIV/AIDS prevention efforts is that small pilot programmes with no chance of duplication or replication are not helpful (World Bank 1999). In an article in Science (Binswanger 2000) the director for rural development and environment at the World Bank gives a stark example of limited coverage in the Kagera Region of Tanzania, where 200,000 of the region’s 1.9 million people are children orphaned by AIDS. There, NGO directors stated that they operate mainly in two out of five districts, leaving three with almost no services, and in the two districts where they do work, they serve no more than an estimated 5 per cent of the population.
Elsewhere, as the UNAIDS recent report states: “…action remains sporadic and patchy rather than comprehensive. ‘Boutique’ projects may provide services for one or two communities, while large areas of the countryside have nothing. Many programmes have yet to become comprehensive in either geographical coverage or content.” (UNAIDS 2000). Indeed such is the lack of information about access and coverage that it is not generally known who has access to, let alone uses, HIV/AIDS related services (Paurvi Bhatt, USAID/DC, Horizons/Alliance Seminar). Estimates of current levels of coverage in sub-Saharan Africa for HIV/AIDS prevention interventions suggest that overall coverage is less than 20% of the target populations in most countries
(Kumaranayake and Watts 2000). Clearly the onus is now on the HIV/AIDS community – including funding organisations - to explore the question of increasing scale and to make efforts, fully cognisant of the risks involved, to identify what programmes or which aspects of their programmes can be scaled up. While there may be consensus on the need to scale up, there is less agreement over the objectives and the most appropriate approaches to scaling up, as will be addressed in the next section.
Source: A Question of Scale
This is an extract from A Question of Scale: The challenge of expanding the impact of non-governmental organisations’ HIV/AIDS efforts in developing countries,
by Jocelyn DeJong, published by the Horizons Project of the Population Council with the International HIV/AIDS Alliance in 2001. To view the whole report follow this link.
To download, complete with graphics, in pdf format (which requires Adobe Acrobat software to read it) follow this link (file size 1.43 Mbytes).
aidsmap resources
Africa news
- HIV prevalence may decline because the most vulnerable are infected and die first
- TB doesn't always increase HIV viral load
- Circumcision may offer men some protection against HPV
Eastern Europe and Russia news
- HIV diagnoses in European MSM have almost doubled since 2000, UK tops the list
- Long hospital stays for TB treatment can increase risk of reinfection with MDR or XDR-TB strains
- Long hospital stays for TB treatment can increase risk of reinfection with MDR or XDR-TB strains
Latin America news
- CD4 cell count increases sustained up to five years in developing-world treatment programmes
- Brazil rejects tenofovir patent
- Immigration and prevention: the effect of migration on risk behaviour
